Man Group plc
- SEC CIK
- 0001637460
- Latest filing
- Aug 14, 2026
AMLX holding history
Amylyx Pharmaceuticals, Inc. in every 13F filed by Man Group plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMLX overviewAll 13F holders of AMLXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −87,352−100.0% | Sold out | Holders |
| Q1 2025 | 87,352 | $309.2K | <0.1% | −12,707−12.7% | Reduced | Holders |
| Q4 2024 | 100,059 | $378.2K | <0.1% | −30,803−23.5% | Reduced | Holders |
| Q3 2024 | 130,862 | $424.0K | <0.1% | +14,733+12.7% | Added | Holders |
| Q2 2024 | 116,129 | $220.6K | <0.1% | +55,450+91.4% | Added | Holders |
| Q1 2024 | 60,679 | $172.3K | <0.1% | +60,679 | New | Holders |